Poor Prognosis of Rare Sarcomeric Gene Variants in Patients with Dilated Cardiomyopathy-Reference-Cited by-同舟云学术

Poor Prognosis of Rare Sarcomeric Gene Variants in Patients with Dilated Cardiomyopathy

Published:2013-10-03 Issue:6 Volume:6 Page:424-428
ISSN:1752-8054
Container-title:Clinical and Translational Science
language:en
Short-container-title:Clinical And Translational Science

Author:

Merlo Marco¹²,Sinagra Gianfranco²,Carniel Elisa¹,Slavov Dobromir¹,Zhu Xiao¹,Barbati Giulia²,Spezzacatene Anita²,Ramani Federica²,Salcedo Ernesto¹,Di Lenarda Andrea³,Mestroni Luisa¹,Taylor Matthew R. G.¹,

Affiliation:

1. Cardiovascular Institute and Adult Medical Genetics; University of Colorado, Aurora; Colorado USA

2. Cardiovascular Department “Ospedali Riuniti,”and University of Trieste; Trieste Italy

3. Cardiovascular Center ASS1; Trieste Italy

Publisher

Wiley

Subject

General Pharmacology, Toxicology and Pharmaceutics,General Biochemistry, Genetics and Molecular Biology,General Medicine,General Neuroscience

Reference33 articles.

1. Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies;Richardson;Circulation,1996

2. Familial dilated cardiomyopathy: cardiac abnormalities are common in asymptomatic relatives and may represent early disease;Baig;J Am Coll Cardiol.,1998

3. Familial dilated cardiomyopathy: evidence for genetic and phenotypic heterogeneity;Mestroni;J Am Coll Cardiol.,1999

4. Clinical and genetic issues in dilated cardiomyopathy: a review for genetics professionals;Hershberger;Genet Med.,2011

5. Inherited cardiomyopathies;Watkins;N Engl J Med.,2011

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Titin: roles in cardiac function and diseases;Frontiers in Physiology;2024-04-10

2. Exploring TTN variants as genetic insights into cardiomyopathy pathogenesis and potential emerging clues to molecular mechanisms in cardiomyopathies;Scientific Reports;2024-03-04

3. Current RNA strategies in treating cardiovascular diseases;Molecular Therapy;2024-03

4. Exploring novel biomarkers in dilated cardiomyopathy‑induced heart failure by integrated analysis and in vitro experiments;Experimental and Therapeutic Medicine;2023-05-16

5. Myosin-Related Dilated Cardiomyopathy;Journal of the American College of Cardiology;2022-10